Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip D Walson

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Clinical Therapeutics|May 4, 2010
Comment on Dr. Finestone's letterPhilip D Walson
Clinical Therapeutics|February 18, 2014
Pediatric drug developmentPhilip D Walson
Clinical Therapeutics|July 9, 2016
To the EditorPhilip D Walson
Therapeutic Drug Monitoring|January 25, 2020
Drug Exposure and Effects in Pregnancy and LactationPhilip D Walson
Clinical Therapeutics|February 25, 2021
In response to Du et al., 2020, 42(9):1799-1810Philip D Walson
Clinical Therapeutics|February 16, 2013
Vaccines update in Clinical TherapeuticsPhilip D Walson
Current Therapeutic Research, Clinical and Experimental|August 8, 2019
Special Meeting Report: Keystone Symposia on Molecular and Cellular Biology, Hannover, Germany, June 4-8, 2018Philip D Walson
Journal of Toxicology. Clinical Toxicology|April 16, 2004
Comment on "Treatment of hyperkalemia in a patient with unrecognized digitalis toxicity"Philip D Walson
Clinical Therapeutics|July 18, 2003
Three drug reviews: one reformulated and one new antifungal agent and optimal dosing of the anticonvulsant gabapentinPhilip D Walson
Clinical Therapeutics|June 29, 2004
Interpreting medical research resultsPhilip D Walson
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Clinical Therapeutics|May 4, 2010
Comment on Dr. Finestone's letterPhilip D Walson
Clinical Therapeutics|February 18, 2014
Pediatric drug developmentPhilip D Walson
Clinical Therapeutics|July 9, 2016
To the EditorPhilip D Walson
Therapeutic Drug Monitoring|January 25, 2020
Drug Exposure and Effects in Pregnancy and LactationPhilip D Walson
Clinical Therapeutics|February 25, 2021
In response to Du et al., 2020, 42(9):1799-1810Philip D Walson
Clinical Therapeutics|February 16, 2013
Vaccines update in Clinical TherapeuticsPhilip D Walson
Current Therapeutic Research, Clinical and Experimental|August 8, 2019
Special Meeting Report: Keystone Symposia on Molecular and Cellular Biology, Hannover, Germany, June 4-8, 2018Philip D Walson
Journal of Toxicology. Clinical Toxicology|April 16, 2004
Comment on "Treatment of hyperkalemia in a patient with unrecognized digitalis toxicity"Philip D Walson
Clinical Therapeutics|July 18, 2003
Three drug reviews: one reformulated and one new antifungal agent and optimal dosing of the anticonvulsant gabapentinPhilip D Walson
Clinical Therapeutics|June 29, 2004
Interpreting medical research resultsPhilip D Walson
Pageof 6